Biblio Discovery — Demo Discovery Service

11 hasil untuk "Puneet Kumar"

Menampilkan 1–11 · 0,17 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-3 11 and MSP-1 19 : PfAMSP-Fu 35

    Aakanksha Kalra; Jyotheeswara Reddy Edula; Puneet Kumar Gupta dkk.

    PLOS ONE, Vol. 11 No. 10 · 2016 · Inggris · PLOS Scopus

    Development of fusion chimeras as potential vaccine candidates is considered as an attractive strategy to generate effective immune responses to more than one antigen using a single construct. Here, we described the design, production, purification and antigenicity of a fusion chimera…

  2. Artikel Jurnal Teks lengkap

    HIV Seroprevalence among Tuberculosis Patients in India, 2006–2007

    Neeraj Raizada; Lakbir Singh Chauhan; Ajay Khera dkk.

    PLoS ONE, Vol. 3 No. 8 · 2008 · Inggris · PLOS Scopus

    Background: Little information exists regarding the burden of HIV among tuberculosis patients in India, and no population-based surveys have been previously reported. A community-based HIV prevalence survey was conducted among tuberculosis patients treated by the national tuberculosis control…

  3. Artikel Jurnal Teks lengkap

    Tuberculosis Management Practices of Private Practitioners in Pune Municipal Corporation, India

    Sandeep Bharaswadkar; Avinash Kanchar; Narendra Thakur dkk.

    PLoS ONE, Vol. 9 No. 6 · 2014 · Inggris · PLOS Scopus

    Background: Private Practitioners (PP) are the primary source of health care for patients in India. Limited representative information is available on TB management practices of Indian PP or on the efficacy of India’s Revised National Tuberculosis Control Programme (RNTCP) to improve the quality of…

  4. Artikel Jurnal Teks lengkap

    Sputum Smear Microscopy at Two Months into Continuation-Phase: Should It Be Done in All Patients with Sputum Smear-Positive Tuberculosis?

    Mohit Padamchand Gandhi; Ajay M. V. Kumar; Manoj Nandkishor Toshniwal dkk.

    PLoS ONE, Vol. 7 No. 6 · 2012 · Inggris · PLOS Scopus

    Background: The Revised National Tuberculosis Control Program (RNTCP) of India recommends follow-up sputum smear examination at two months into the continuation phase of treatment. The main intent of this (mid-CP) follow-up is to detect patients not responding to treatment around two-three months…

  5. Artikel Jurnal Teks lengkap

    From Where Are Tuberculosis Patients Accessing Treatment in India? Results from a Cross-Sectional Community Based Survey of 30 Districts

    Srinath Satyanarayana; Sreenivas Achutan Nair; Sarabjit Singh Chadha dkk.

    PLoS ONE, Vol. 6 No. 9 · 2011 · Inggris · PLOS Scopus

    Background: Tuberculosis (TB) notification in India by the Revised National TB Control Programme (RNTCP) provides information on TB patients registered for treatment from the programme. There is limited information about the proportion of patients treated for TB outside RNTCP and where these…

  6. Artikel Jurnal Teks lengkap

    Source of Previous Treatment for Re-Treatment TB Cases Registered under the National TB Control Programme, India, 2010

    Kuldeep Singh Sachdeva; Srinath Satyanarayana; Puneet Kumar Dewan dkk.

    PLoS ONE, Vol. 6 No. 7 · 2011 · Inggris · PLOS Scopus

    Background: In 2009, nearly half (289,756) of global re-treatment TB notifications are from India; no nationally-representative data on the source of previous treatment was available to inform strategies for improvement of initial TB treatment outcome. Objectives: To assess the source of previous…

  7. Artikel Jurnal Teks lengkap

    Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi

    Srinath Satyanarayana; Roopa Shivashankar; Ram Pal Vashist dkk.

    PLoS ONE, Vol. 5 No. 10 · 2010 · Inggris · PLOS Scopus

    Background: Childhood tuberculosis (TB) patients under India's Revised National TB Control Programme (RNTCP) are managed using diagnostic algorithms and directly observed treatment with intermittent thrice-weekly short-course treatment regimens for 6–8 months. The assignment into pre-treatment…

  8. Artikel Jurnal Teks lengkap

    Factors Associated with Delays in Treatment Initiation after Tuberculosis Diagnosis in Two Districts of India

    Durba Paul; Arundhathi Busireddy; Sharath Burugina Nagaraja dkk.

    PLoS ONE, Vol. 7 No. 7 · 2012 · Inggris · PLOS Scopus

    Background: Excessive time between diagnosis and initiation of tuberculosis (TB) treatment contributes to ongoing TB transmission and should be minimized. In India, Revised National TB Control Programme (RNTCP) focuses on indicator start of treatment within 7 days of diagnosis for patients with…

  9. Artikel Jurnal Teks lengkap

    Can Follow-Up Examination of Tuberculosis Patients Be Simplified? A Study in Chhattisgarh, India

    Debashish Kundu; Ajay M. V. Kumar; Srinath Satyanarayana dkk.

    PLoS ONE, Vol. 7 No. 12 · 2012 · Inggris · PLOS Scopus

    Background: Each follow-up during the course of tuberculosis treatment currently requires two sputum examinations. However, the incremental yield of the second sputum sample during follow-up of different types of tuberculosis patients has never been determined precisely. Objectives: To assess the…

  10. Artikel Jurnal Teks lengkap

    Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175

    Chetan E. Chitnis; Paushali Mukherjee; Shantanu Mehta dkk.

    PLOS ONE, Vol. 10 No. 4 · 2015 · Inggris · PLOS Scopus

    Background: A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant blood stage vaccine candidate against Plasmodium falciparum malaria, composed of a physical mixture of two recombinant proteins…